Effects of ulinastatin and traneamic acid on platelet during cardiopulmonary bypass

Chinese Pharmaceutical Journal

Volumn 40, Issue 13, 2005, Pages

  Jin, Xiu Guo ^a   Fang, Guo An ^a   Liu, Bo ^a   Liu, Xiao Guang ^a   Zhuang, Xiao Ling ^a   Fang, Han Bo ^a  

^a People's Hospital of Zhoushan City   (China)

Author keywords

Cardiopulmonary bypass; Platelet; Traneamic acid; Ulinastatin

Indexed keywords

BIOLOGICAL MEMBRANES; CARDIOLOGY; FLUORESCENCE; PATIENT TREATMENT; PROTEINS;

CARDIOPULMONARY BYPASS; PLATELETS; TRANEAMIC ACID; ULINASTATIN;

DRUG PRODUCTS;

ANTIFIBRINOLYTIC AGENT; FIBRINOGEN RECEPTOR; SODIUM CHLORIDE; TRANEAMIC ACID; ULINASTATIN; UNCLASSIFIED DRUG;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; PROTEIN EXPRESSION; THROMBOCYTE;

EID: 24944542302     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Zilla P, Fasoll R, Groscurth P, et al. Blood platelets in cardiopulmonary bypass operation recovery occurs after initial stimulation rather than continual activation[J]. J Thorac Cardiovasc Surg, 1989, 98: 379.
2. Blauhut B, Harringer W, Bettelhiem P, et al. Comparson of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 1994, 108: 1083.